Bramah N Singh
age ~87
from Encino, CA
- Also known as:
-
- Bramah Nand Singh
- Bramah Dr Singh
- Bramah R Singh
- Nand Singh Bramah
- Nand Bramah Singh
- Phone and address:
-
16979 Encino Hills Dr, Van Nuys, CA 91436
818 986-4853
Bramah Singh Phones & Addresses
- 16979 Encino Hills Dr, Encino, CA 91436 • 818 986-4853
- Van Nuys, CA
- San Francisco, CA
- 10713 Mountain View Ave, Loma Linda, CA 92354
- 500 Elliott Ave W, Seattle, WA 98119
- West Hollywood, CA
- San Bernardino, CA
- 16979 Encino Hills Dr, Van Nuys, CA 91436
Work
-
Position:Medical Professional
Education
-
School / High School:University Of Otago, School Of Medicine1963
Languages
English • Chinese
Specialities
Internal Medicine
Isbn (Books And Publications)
-
Silent Myocardial Ischemia And Angina: Prevalence, Prognostic, And Therapeutic Significance
view source -
Author:Bramah Singh
-
ISBN #:0080360785
-
Electropharmacological Control Of Cardiac Arrhythmias
view source -
Author:Bramah Singh
-
ISBN #:0879935146
-
Cardiovascular Pharmacology And Therapeutics
view source -
Author:Bramah N. Singh
-
ISBN #:0443088144
-
Electropharmacologic Control Of Cardiac Arrythmias: To Delay Conduction Or To Prolong Refractoriness?
view source -
Author:Bramah N. Singh
-
ISBN #:0879935669
Medicine Doctors
Dr. Bramah N Singh, Los Angeles CA - MD (Doctor of Medicine)
view sourceSpecialties:
Internal Medicine
Address:
200 Ucla Medical Plz Suite 365, Los Angeles, CA 90095
310 794-9718 (Phone)
310 794-9718 (Phone)
Languages:
English
Chinese
Chinese
Education:
Medical School
University Of Otago, School Of Medicine
Graduated: 1963
University Of Otago, School Of Medicine
Graduated: 1963
Us Patents
-
Sustained Release Formulations Of Sotalol
view source -
US Patent:20090047346, Feb 19, 2009
-
Filed:Sep 5, 2008
-
Appl. No.:12/231896
-
Inventors:Bramah N. Singh - Encino CA, US
-
International Classification:A61K 31/18
A61K 9/22
A61P 9/00 -
US Classification:424468, 514605
-
Abstract:Sustained release compositions of sotalol, or a pharmaceutically acceptable salt thereof, are provided. In certain examples, sotalol, or a pharmaceutically acceptable salt thereof, may be administered in an effective amount to provide a therapeutic effect to a patient, such as, for example, a patient suffering from a cardiac disorder. In some examples, sotalol combined with a sustained release system may be administered to provide a sustained release of sotalol for a desired period, e.g., at least about 24 hours.
-
Sustained Release Formulations Of Sotalol
view source -
US Patent:20060105044, May 18, 2006
-
Filed:May 20, 2005
-
Appl. No.:11/134089
-
Inventors:Bramah Singh - Encino CA, US
-
International Classification:A61K 9/14
-
US Classification:424486000
-
Abstract:Sustained release compositions of sotalol, or a pharmaceutically acceptable salt thereof, are provided. In certain examples, sotalol, or a pharmaceutically acceptable salt thereof, may be administered in an effective amount to provide a therapeutic effect to a patient, such as, for example, a patient suffering from a cardiac disorder. In some examples, sotalol combined with a sustained release system may be administered to provide a sustained release of sotalol for a desired period, e.g., at least about 24 hours.
-
Methods Of Treatment Using Sustained Release Sotalol Formulations
view source -
US Patent:20200345670, Nov 5, 2020
-
Filed:Feb 14, 2020
-
Appl. No.:16/791835
-
Inventors:- San Mateo CA, US
Bramah N. Singh - Encino CA, US -
International Classification:A61K 31/18
A61K 9/00
A61K 47/36
A61K 9/20 -
Abstract:Sustained release compositions of sotalol, or a pharmaceutically acceptable salt thereof, are provided. In certain examples, sotalol, or a pharmaceutically acceptable salt thereof, may be administered in an effective amount to provide a therapeutic effect to a patient, such as, for example, a patient suffering from a cardiac disorder. In some examples, sotalol combined with a sustained release system may be administered to provide a sustained release of sotalol for a desired period, e.g., at least about 24 hours.
-
Methods Of Treatment Using Sustained Release Sotalol Formulations
view source -
US Patent:20180344675, Dec 6, 2018
-
Filed:Apr 26, 2018
-
Appl. No.:15/963949
-
Inventors:- San Mateo CA, US
Bramah N. Singh - Encino CA, US -
International Classification:A61K 31/18
A61K 47/36
A61K 9/00
A61K 9/20 -
Abstract:Sustained release compositions of sotalol, or a pharmaceutically acceptable salt thereof, are provided. In certain examples, sotalol, or a pharmaceutically acceptable salt thereof, may be administered in an effective amount to provide a therapeutic effect to a patient, such as, for example, a patient suffering from a cardiac disorder. In some examples, sotalol combined with a sustained release system may be administered to provide a sustained release of sotalol for a desired period, e.g., at least about 24 hours.
-
Methods Of Treatment Using Sustained Release Sotalol Formulations
view source -
US Patent:20170239199, Aug 24, 2017
-
Filed:Mar 2, 2017
-
Appl. No.:15/448482
-
Inventors:- San Mateo CA, US
Bramah N. Singh - Encino CA, US -
International Classification:A61K 31/18
A61K 9/20 -
Abstract:Sustained release compositions of sotalol, or a pharmaceutically acceptable salt thereof, are provided. In certain examples, sotalol, or a pharmaceutically acceptable salt thereof, may be administered in an effective amount to provide a therapeutic effect to a patient, such as, for example, a patient suffering from a cardiac disorder. In some examples, sotalol combined with a sustained release system may be administered to provide a sustained release of sotalol for a desired period, e.g., at least about 24 hours.
Name / Title
Company / Classification
Phones & Addresses
Bramah Singh MD,MBBS,PHD
Internist
Internist
200 Ucla Medical Plz, Los Angeles, CA 90095
310 825-8811
310 825-8811
President
LAKSHYA ENTERPRISES INC
16979 Encino Hl Dr, Encino, CA 91436
Youtube
Get Report for Bramah N Singh from Encino, CA, age ~87